Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group - Buzdar,A.; Jonat,W.; Howell,A. (J Clin Oncol, 1996)